|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Inari Medical insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Inari Medical insider buys are important for investors to follow.
Date | Insider | Price | Amount |
11-8-2023 Insider Buy |
Donald B. Milder Director |
$53.44
CAGR »
|
$2,998,063.00 56,100 shares |
11-15-2021 Insider Buy |
Jonathan D. Root
|
$85.03
CAGR »
|
$28,484.10 335 shares |
5-27-2020 Insider Buy |
Gilde Healthcare U.A. Cooperatieve IV >10% Owner |
$19.00
CAGR »
|
$6,504,251.00 342,329 shares |
5-27-2020 Insider Buy |
Mitch C. Hill, Chief Financial Officer |
$19.00
CAGR »
|
$172,900.00 9,100 shares |
5-27-2020 Insider Buy |
Andrew Hykes Chief Commercial Officer |
$19.00
CAGR »
|
$107,350.00 5,650 shares |
5-27-2020 Insider Buy |
Cynthia L. Lucchese Director |
$19.00
CAGR »
|
$533,729.00 28,091 shares |
5-27-2020 Insider Buy |
Donald B. Milder Director and >10% Owner |
$19.00
CAGR »
|
$4,556,979.00 239,841 shares |
5-27-2020 Insider Buy |
Catherine M. Szyman Director |
$19.00
CAGR »
|
$533,729.00 28,091 shares |
5-27-2020 Insider Buy |
Thomas Tu Chief Medical Officer |
$19.00
CAGR »
|
$533,729.00 28,091 shares |
Also See: Institutional Holders of NARI
Also See: SEC filings
Below we present the annualized performance delivered by Inari Medical stock since 11-8-2023 (the date of the most recent
insider purchase). The performance of the investment from the time Inari Medical insider buying occurred is the ultimate
test of whether insiders were right about NARI being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/09/2023 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$53.97 |
|
End price/share: |
$42.03 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-22.12% |
|
Annualized Gain: |
-46.14% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,788.00 |
|
Years: |
0.48 |
|
Inari Medical Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Inari Medical insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NARI
|
|